Register for the 2024 Personnel Placement Service (PPS) to request an interview.

Details

Posted: 10-Oct-24

Location: Tampa, Florida

Type: Residency PGY-2

Categories:

Clinical Pharmacist

Graduate Program

Pharmacy

Job Setting:

Hospital/Institutional

Specialty Practice Areas:

Oncology

Additional Information:

4 openings available.

The Moffitt Cancer Center (MCC) Department of Pharmacy Specialty Oncology Pharmacy Practice Residency is a 12-month program developed to meet or exceed all practice standards established by the American Society of Health-Systems Pharmacists (ASHP). This specialized, ASHP-accredited residency is designed to further develop the resident's clinical oncology skills. Specifically, the resident will be actively involved in managing the therapeutic decisions and clinical outcomes of cancer patients in an interdisciplinary environment.

Residents participate in all aspects of oncology pharmacy practice pertaining to clinical practice and outcomes, research, and education. MCC PGY-2 oncology residency program is divided predominantly into two or four-week blocks that allow residents to focus on patient care in a variety of cancer subtypes. Several inpatient and ambulatory rotations are distributed over the year to allow for a comprehensive learning experience.

Our program also allows for tailoring the experience to residents’ interests and learning needs by making several elective blocks available. This allows residents to choose electives such as Academia, Precision Medicine, Pain and Palliative Care, and Immune Cell Therapy (ICE-T), etc.  Additional learning experiences may be developed based on resident interest and preceptor availability. Clinical rotations are augmented with disease-specific Oncology Forums, Pharmacy Grand Rounds and Journal clubs. Residents also gain experience in Infusion Center, Investigational Drug Services (IDS), Admin and Pharmacy Staffing.

Taken together, this variety of experiences will prepare the resident to become a successful clinical pharmacist, leader and educator in oncology.

A Doctor of Pharmacy degree from an ACPE-accredited College of Pharmacy is required, as well as anticipated completion of an ASHP-accredited pharmacy practice residency (PGY-1) and eligibility for licensure or current licensure in the state of Florida. 

About Moffitt Cancer Center

Moffitt Cancer Center (MCC) is a non profit National Cancer Institute Designated Comprehensive Cancer Center located in Tampa, Florida. HLMCC was established in 1986 and sees approximately 25,000 new patients annually, resulting in 290,000 clinic visits and an average daily inpatient census of 240. As an oncology health care facility, MCC has achieved exemplary reviews by all regulatory agencies, including the Joint Commission of American Hospital Organizations (JCAHO), the Florida Department of Pharmacy Regulation (DPR), American Nurses Credentialing Center (ANCC) Magnet designation, and the Drug Enforcement Agency (DEA). Moffitt Cancer Center is ranked on the US News and World Report Best Hospitals for Cancer, and has received this ranking for the last 20 years. Moffitt has research affiliations with the following national collaborative groups: National Cancer Institute (NCI), Southwest Cooperative Oncology Group (SWOG), Gynecologic Oncology Group (GOG), and Radiation Therapy Oncology Group (RTOG). The MCC Department of Pharmacy has supported pharmacy residency programs and training for almost 30 years in this large and diverse patient base.

Connections working at Moffitt Cancer Center